| Class 1 Device Recall Subdural Electrode | |
Date Initiated by Firm | December 18, 2012 |
Date Posted | March 02, 2013 |
Recall Status1 |
Terminated 3 on October 15, 2014 |
Recall Number | Z-0892-2013 |
Recall Event ID |
64136 |
510(K)Number | K053363 |
Product Classification |
Electrode, cortical - Product Code GYC
|
Product | Ad-Tech Medical Instrument Corporation Macro Micro Subdural Electrode. For temporary (<30 days) use with recording, monitoring and stimulation equipment, for the recording, monitoring and stimulation of electrical signals on the surface level of the brain. The recording of electrical activity supports definition of the location of epileptogenic foci and brain mapping. |
Code Information |
REF numbers (catalog numbers): EG10A-SP10N-000, EG34B-SP10X-000, EGD7A-MP12N-000, EGE4A-SP10N-000, EGE4A-SP10X-000, QG10B-SP10X-000, QG10C-SP10N-000, QG10D-SP10N-000, QG11A-SP10X-000, QG16A-SP10X-000, QG17A-SP10X-000, QG18A-SP10N-000, QG18A-SP10X-000, QG20B-SP10N-000, QG20B-SP10X-000, QG20C-SP10N-000, QG20C-SP10X-000, QG20D-SP10X-200, QG20E-SP10X-000, QG20F-SP10X-000, QG24A-SP10N-000, QG26A-SP10N-000, QG32A-SP10X-000, QG32B-SP10X-000, QG36A-SP10N-000, QG36A-SP10X-000, QG36B-SP10N-000, QG44A-SP10X-000, QG53A-SP10X-000, QG66A-SP85N-000, QG69A-SP10N-000, QG88A-SP10X-000, QG96A-SP10N-000, QG96A-SP10X-000, QG96C-SP10X-000, QG96D-SP10X-000, QGC6A-SP07N-000, QGC8A-SP10N-000, QGC8A-SP10X-000, QGC8B-SP10X-000, QGC8C-SP10X-000, QGC8D-SP10N-000, QGC8E-SP10X-000, QGC8F-SP10X-000, QS20A-SP10N-000, QS40B-SP10X-000, Lot numbers: 208140314, 208140343, 208140344, 208140353, 208140354, 208140362, 208140369, 208140374, 208140381, 208140382, 208140387, 208140390, 208140395, 208140398, 208140399, 208140414, 208140417, 208140421, 208140431, 208140443, 208140445, 208140450, 208140452, 208140453, 208140458, 019020, 208140356R, 208140357R, 208140452R, C010180001, C702201001, C703160006, C704040001, C800250002, C800350004, C801240003, C802220003, C802220005, C802220006, C805210003, C805210004, C908221002, G012111001, G012140002, G015020002, G016240001, G017250004, G017250005, G017250006, G018011001, G018011002, G018011003, G019021002, G019021003, G019150003, G112270004, G114160001, G114160002, G115080002, G115170004, G115280005, G119020004, G211220001, G608060002, G704150001, G805270001, G900211002, G903011001, G903080003, S903080004, S905280003. Recall exanded on 5/2/2013 to include additional Macro Micro Subdural Electrodes: REF numbers (catalog numbers): CG-64BPX-F436, CMMS-22PX-F478
CG-32BPX-F412, CGIE-98BPX-F341, CGIE-82BPN-F377, CMMS-69PN-F480, CGIE-98BPN-F341, CG-9SN-F496, CG-32BPX-F426, CG-16BPX-F445, CG-16BPX-F446, CG-256PX-F425, CGIE-39BPX-F442, CG-46BPX-F465, CG-64BPX-F419, CG-32BPX-F418. Lot numbers: 20814044, 208140447, 208140463, 208140463, 208140476, 208140463, 08140463, 208140424, 208140439, G119221001,G212040002, G216040002, 218190, 208140431, 208140450, 208140432, 208140433, 208140420, 208140437, 208140450, 208140422, 208140422, 208140422, 208140422 |
Recalling Firm/ Manufacturer |
Ad-Tech Medical Instrument Corporation 1901 William St Racine WI 53404-1876
|
For Additional Information Contact | 262-634-1555 |
Manufacturer Reason for Recall | The microelectrodes are not flush with the silastic substrate, may contain sharp edges capable of abrading the cortical surface, and may have remaining pieces which may fracture and remain in the cortical tissue with the electrode is explanted.
Recall expanded on 5/2/2013 to include additional Macro Micro Subdural Electrodes. |
FDA Determined Cause 2 | Device Design |
Action | AD-TECH Medical Instrument Corporation sent an "Urgent Medical Device Recall" letter dated December 18, 2012 to all affected consignees. The letter described the Reason for the Voluntary Recall, Risk to Health, Actions to be taken by the Customer, Product and Distribution Information, Type of Action by Ad-Tech Medical Instrument Corporation and Other Information. Consignees were instructed to quarantine the affected product and contact the firm for a Return Material Authorization number. If the product have been further distributed consignees were advised to notify their customers of the recall. The letter requested consignees to return the Acknowledgement and Receipt Form.
For questions contact your Ad-Tech Clinical Specialist.
Expanded recall letters dated May 2, 2013 were sent out April 29, 2013. The letters were formatted as the initial ones sent on 12/18/2013. |
Quantity in Commerce | 144 (103 US; 41 OUS) |
Distribution | Worldwide Distribution - USA Nationwide including the states of CA, GA, LA, MA, MD, MI, MN, NH, PA, RI, TX, UT, WI, NY IA, WI and the countries of: Australia, CANADA, ENGLAND, JAPAN, KOREA, SPAIN, FRANCE, and SWITZERLAND. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = GYC
|
|
|
|